Specifically, our findings support a model in which YAP:TEAD-mediated transcription activates an AXL- and EGFR-initiated signaling cascade resulting in the activation of mTOR in epithelial cells, thus representing an actionable target to prevent tumor initiation. This evidence concerns the gene YAP1 and neoplasm.